COVID-19
TOOLBOX
Filter
132
Featured
Language
Document type
44
43
14
11
7
5
4
3
1
Countries / Regions
16
8
8
6
6
6
6
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
51
12
12
7
6
5
5
4
4
4
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
55
2
1
Manufacturers: SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])] Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)] Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir ... more
AstraZeneca-SKBio in South Korea and Serum Institute of India
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
Februrar 2021
INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit Vektor-Impfstoff –
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages 18 Febr. 2021
11 March 2021
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine 10 March 2021
7 April 2021
17 March 2021
July 2021
21 Dec 2021. Slideset updated regularly to include the latest data and guidance on COVID-19 vaccines, including implications of emerging SARS-CoV-2 variants